Integrins and their ligands in rheumatoid arthritis

Arthritis Research and Therapy

Volumn 13, Issue 5, 2011, Pages

  Lowin, Torsten ^a   Straub, Rainer H ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; BETA INTEGRIN; BETA2 INTEGRIN; BETA3 INTEGRIN; BETA5 INTEGRIN; COLLAGEN; COLLAGEN TYPE 10; COLLAGEN TYPE 11; COLLAGEN TYPE 2; COLLAGEN TYPE 9; FIBRONECTIN; GAMMA INTERFERON; INTEGRIN; INTEGRIN RECEPTOR; INTERLEUKIN 17; INTERLEUKIN 6; LAMININ; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VERY LATE ACTIVATION ANTIGEN 1; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 3; VERY LATE ACTIVATION ANTIGEN 4; VERY LATE ACTIVATION ANTIGEN 5; VITRONECTIN; CYTOKINE; LIGAND;

B LYMPHOCYTE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; ENDOTHELIUM; EXTRACELLULAR MATRIX; FIBROBLAST; GLANZMANN DISEASE; LIGAND BINDING; MACROPHAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIUM; T LYMPHOCYTE; TH17 CELL; ANIMAL; CELL ADHESION; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; PROTEIN BINDING;

ANIMALS; ARTHRITIS, RHEUMATOID; CELL ADHESION; CYTOKINES; EXTRACELLULAR MATRIX; HUMANS; INTEGRINS; LIGANDS; PROTEIN BINDING;

EID: 81255144265     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3464     Document Type: Review

References (50)

1. Stupack DG. Integrins as a distinct subtype of dependence receptors. Cell Death Differ 2005, 12:1021-1030. 10.1038/sj.cdd.4401658, 15933741.
2. Stupack DG, Puente XS, Boutsaboualoy S, Storgard CM, Cheresh DA. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol 2001, 155:459-470. 10.1083/jcb.200106070, 2150834, 11684710.
3. Davis LS. A question of transformation: the synovial fibroblast in rheumatoid arthritis. Am J Pathol 2003, 162:1399-1402. 10.1016/S0002-9440(10)64272-1, 1851189, 12707022.
4. Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 2010, 233:233-255. 10.1111/j.0105-2896.2009.00859.x, 2913689, 20193003.
5. Lowin T, Straub RH, Neumann E, Bosserhoff A, Vogel C, Moissl C, Anders S, Muller-Ladner U, Schedel J. Glucocorticoids increase alpha5 integrin expression and adhesion of synovial fibroblasts but inhibit ERK signaling, migration, and cartilage invasion. Arthritis Rheum 2009, 60:3623-3632. 10.1002/art.24985, 19950288.
6. Wollheim FA. Predictors of joint damage in rheumatoid arthritis. APMIS 1996, 104:81-93. 10.1111/j.1699-0463.1996.tb00691.x, 8619919.
7. Werb Z, Tremble PM, Behrendtsen O, Crowley E, Damsky CH. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol 1989, 109:877-889. 10.1083/jcb.109.2.877, 2115739, 2547805.
8. Sarkissian M, Lafyatis R. Integrin engagement regulates proliferation and collagenase expression of rheumatoid synovial fibroblasts. J Immunol 1999, 162:1772-1779.
9. Attur MG, Dave MN, Clancy RM, Patel IR, Abramson SB, Amin AR. Functional genomic analysis in arthritis-affected cartilage: yin-yang regulation of inflammatory mediators by alpha 5 beta 1 and alpha V beta 3 integrins. J Immunol 2000, 164:2684-2691.
10. Postigo AA, Garcia-Vicuna R, Laffon A, Sanchez-Madrid F. The role of adhesion molecules in the pathogenesis of rheumatoid arthritis. Autoimmunity 1993, 16:69-76. 10.3109/08916939309010649, 8136468.
11. Liao HX, Haynes BF. Role of adhesion molecules in the pathogenesis of rheumatoid arthritis. Rheum Dis Clin North Am 1995, 21:715-740.
12. Laudanna C, Kim JY, Constantin G, Butcher E. Rapid leukocyte integrin activation by chemokines. Immunol Rev 2002, 186:37-46. 10.1034/j.1600-065X.2002.18604.x, 12234360.
13. Yee KL, Weaver VM, Hammer DA. Integrin-mediated signalling through the MAP-kinase pathway. IET Syst Biol 2008, 2:8-15. 10.1049/iet-syb:20060058, 18248081.
14. Zutter MM, Santoro SA, Staatz WD, Tsung YL. Re-expression of the alpha 2 beta 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci USA 1995, 92:7411-7415. 10.1073/pnas.92.16.7411, 41349, 7638207.
15. Rinaldi N, Barth T, Henne C, Mechterscheimer G, Moller P. Synoviocytes in chronic synovitis in situ and cytokine stimulated synovial cells in vitro neo-express alpha 1, alpha 3 and alpha 5 chains of beta 1 integrins. Virchows Arch 1994, 425:171-180.
16. Johnson BA, Haines GK, Harlow LA, Koch AE. Adhesion molecule expression in human synovial tissue. Arthritis Rheum 1993, 36:137-146.
17. Rinaldi N, Weis D, Brado B, Schwarz-Eywill M, Lukoschek M, Pezzutto A, Keilholz U, Barth TF. Differential expression and functional behaviour of the alpha v and beta 3 integrin subunits in cytokine stimulated fibroblast-like cells derived from synovial tissue of rheumatoid arthritis and osteoarthritis in vitro . Ann Rheum Dis 1997, 56:729-736. 10.1136/ard.56.12.729, 1752301, 9496152.
18. Pirila L, Aho H, Roivainen A, Konttinen YT, Pelliniemi LJ, Heino J. Identification of alpha6beta1 integrin positive cells in synovial lining layer as type B synoviocytes. J Rheumatol 2001, 28:478-484.
19. Pfaff M, Aumailley M, Specks U, Knolle J, Zerwes HG, Timpl R. Integrin and Arg-Gly-Asp dependence of cell adhesion to the native and unfolded triple helix of collagen type VI. Exp Cell Res 1993, 206:167-176. 10.1006/excr.1993.1134, 8387021.
20. Davis GE. Affinity of integrins for damaged extracellular matrix: alpha v beta 3 binds to denatured collagen type I through RGD sites. Biochem Biophys Res Commun 1992, 182:1025-1031. 10.1016/0006-291X(92)91834-D, 1540151.
21. Rubio MA, Sotillos M, Jochems G, Alvarez V, Corbi AL. Monocyte activation: rapid induction of alpha 1/beta 1 (VLA-1) integrin expression by lipopolysaccharide and interferon-gamma. Eur J Immunol 1995, 25:2701-2705. 10.1002/eji.1830250945, 7589148.
22. Takahashi H, Soderstrom K, Nilsson E, Kiessling R, Patarroyo M. Integrins and other adhesion molecules on lymphocytes from synovial fluid and peripheral blood of rheumatoid arthritis patients. Eur J Immunol 1992, 22:2879-2885. 10.1002/eji.1830221119, 1385154.
23. Senger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, Detmar M. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc Natl Acad Sci USA 1997, 94:13612-13617. 10.1073/pnas.94.25.13612, 28354, 9391074.
24. Boisvert M, Gendron S, Chetoui N, Aoudjit F. Alpha2 beta1 integrin signaling augments T cell receptor-dependent production of interferon-gamma in human T cells. Mol Immunol 2007, 44:3732-3740. 10.1016/j.molimm.2007.04.003, 17521731.
25. de Fougerolles AR, Sprague AG, Nickerson-Nutter CL, Chi-Rosso G, Rennert PD, Gardner H, Gotwals PJ, Lobb RR, Koteliansky VE. Regulation of inflammation by collagen-binding integrins alpha1beta1 and alpha2beta1 in models of hypersensitivity and arthritis. J Clin Invest 2000, 105:721-729. 10.1172/JCI7911, 377459, 10727440.
26. Boisvert M, Chetoui N, Gendron S, Aoudjit F. Alpha2beta1 integrin is the major collagen-binding integrin expressed on human Th17 cells. Eur J Immunol 2010, 40:2710-2719. 10.1002/eji.201040307, 20806289.
27. Miner JH. Laminins and their roles in mammals. Microsc Res Tech 2008, 71:349-356. 10.1002/jemt.20563, 18219670.
28. Schneider M, Voss B, Rauterberg J, Menke M, Pauly T, Miehlke RK, Friemann J, Gerlach U. Basement membrane proteins in synovial membrane: distribution in rheumatoid arthritis and synthesis by fibroblast-like cells. Clin Rheumatol 1994, 13:90-97. 10.1007/BF02229873, 8187452.
29. Hoberg M, Rudert M, Pap T, Klein G, Gay S, Aicher WK. Attachment to laminin-111 facilitates transforming growth factor beta-induced expression of matrix metalloproteinase-3 in synovial fibroblasts. Ann Rheum Dis 2007, 66:446-451. 1856036, 17124250.
30. Pankov R, Yamada KM. Fibronectin at a glance. J Cell Sci 2002, 115:3861-3863. 10.1242/jcs.00059, 12244123.
31. Yasuda T. Cartilage destruction by matrix degradation products. Mod Rheumatol 2006, 16:197-205. 10.1007/s10165-006-0490-6, 2780665, 16906368.
32. Davis LS, Oppenheimer-Marks N, Bednarczyk JL, McIntyre BW, Lipsky PE. Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules. J Immunol 1990, 145:785-793.
33. Kitagawa A, Miura Y, Saura R, Mitani M, Ishikawa H, Hashiramoto A, Yoshiya S, Shiozawa S, Kurosaka M. Anchorage on fibronectin via VLA-5 (alpha5beta1 integrin) protects rheumatoid synovial cells from Fas-induced apoptosis. Ann Rheum Dis 2006, 65:721-727. 10.1136/ard.2005.041707, 1798166, 16249227.
34. Zeisel MB, Druet VA, Wachsmann D, Sibilia J. MMP-3 expression and release by rheumatoid arthritis fibroblast-like synoviocytes induced with a bacterial ligand of integrin alpha5beta1. Arthritis Res Ther 2005, 7:R118-R126. 10.1186/ar1462, 1064889, 15642131.
35. Alsaleh G, Francois A, Knapp AM, Schickel JN, Sibilia J, Pasquali JL, Gottenberg JE, Wachsmann D, Soulas-Sprauel P. Synovial fibroblasts promote immunoglobulin class switching by a mechanism involving BAFF. Eur J Immunol 2011, 41:2113-2122. 10.1002/eji.201041194, 21557212.
36. Hyun YM, Chung HL, McGrath JL, Waugh RE, Kim M. Activated integrin VLA-4 localizes to the lamellipodia and mediates T cell migration on VCAM-1. J Immunol 2009, 183:359-369. 10.4049/jimmunol.0803388, 2731303, 19542447.
37. Raychaudhuri A, Chou M, Weetall M, Jeng AY. Blockade of integrin VLA-4 prevents inflammation and matrix metalloproteinase expression in a murine model of accelerated collagen-induced arthritis. Inflammation 2003, 27:107-113. 10.1023/A:1023282701505, 12797550.
38. Jacq L, Garnier S, Dieude P, Michou L, Pierlot C, Migliorini P, Balsa A, Westhovens R, Barrera P, Alves H, Vaz C, Fernandes M, Pascual-Salcedo D, Bombardieri S, Dequeker J, Radstake TR, Van Riel P, van de Putte L, Lopes-Vaz A, Glikmans E, Barbet S, Lasbleiz S, Lemaire I, Quillet P, Hilliquin P, Teixeira VH, Petit-Teixeira E, Mbarek H, Prum B, Bardin T, et al. The ITGAV rs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: a family-based study. Arthritis Res Ther 2007, 9:R63. 10.1186/ar2221, 2206364, 17615072.
39. Charo IF, Nannizzi L, Smith JW, Cheresh DA. The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin. J Cell Biol 1990, 111:2795-2800. 10.1083/jcb.111.6.2795, 2116382, 1703545.
40. Nakamura I, Duong le T, Rodan SB, Rodan GA. Involvement of alpha(v)beta3 integrins in osteoclast function. J Bone Miner Metab 2007, 25:337-344. 10.1007/s00774-007-0773-9, 17968485.
41. Wilder RL. Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases. Ann Rheum Dis 2002, 61(Suppl 2):ii96-ii99. 1766704, 12379637.
42. Alghisi GC, Ponsonnet L, Ruegg C. The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells. PLoS One 2009, 4:e4449. 10.1371/journal.pone.0004449, 2636874, 19212436.
43. Neumann E, Gay S, Muller-Ladner U. The RANK/RANKL/osteoprotegerin system in rheumatoid arthritis: new insights from animal models. Arthritis Rheum 2005, 52:2960-2967. 10.1002/art.21361, 16200575.
44. Lindsley HB, Smith DD, Cohick CB, Koch AE, Davis LS. Proinflammatory cytokines enhance human synoviocyte expression of functional intercellular adhesion molecule-1 (ICAM-1). Clin Immunol Immunopathol 1993, 68:311-320. 10.1006/clin.1993.1132, 8103722.
45. Jasin HE, Lightfoot E, Davis LS, Rothlein R, Faanes RB, Lipsky PE. Amelioration of antigen-induced arthritis in rabbits treated with monoclonal antibodies to leukocyte adhesion molecules. Arthritis Rheum 1992, 35:541-549. 10.1002/art.1780350508, 1374251.
46. Suchard SJ, Stetsko DK, Davis PM, Skala S, Potin D, Launay M, Dhar TG, Barrish JC, Susulic V, Shuster DJ, McIntyre KW, McKinnon M, Salter-Cid L. An LFA-1 (alphaLbeta2) small-molecule antagonist reduces inflammation and joint destruction in murine models of arthritis. J Immunol 2010, 184:3917-3926. 10.4049/jimmunol.0901095, 20190141.
47. Major EO. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 2010, 61:35-47. 10.1146/annurev.med.080708.082655, 19719397.
48. Bullard DC, Hurley LA, Lorenzo I, Sly LM, Beaudet AL, Staite ND. Reduced susceptibility to collagen-induced arthritis in mice deficient in intercellular adhesion molecule-1. J Immunol 1996, 157:3153-3158.
49. Kavanaugh AF, Davis LS, Jain RI, Nichols LA, Norris SH, Lipsky PE. A phase I/II open label study of the safety and efficacy of an anti-ICAM-1 (intercellular adhesion molecule-1; CD54) monoclonal antibody in early rheumatoid arthritis. J Rheumatol 1996, 23:1338-1344.
50. Vuorte J, Lindsberg PJ, Kaste M, Meri S, Jansson SE, Rothlein R, Repo H. Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood. J Immunol 1999, 162:2353-2357.